Loading...

Purified anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30-F11_Pure_071608.jpg
BALB/c splenocytes stained with 30-F11 purified, followed by anti-rat IgG FITC
  • 30-F11_Pure_071608.jpg
    BALB/c splenocytes stained with 30-F11 purified, followed by anti-rat IgG FITC
  • 30-F11_Pure_CD45_Antibody_2_102518
    Fresh, frozen mouse spleen was stained with purified CD45 clone 30-F11 conjugated and detected with a FITC CODEX™ oligonucleotide duplex (red). Samples were counterstained with CollagenIV Cy5 (green). Data generated at Akoya Biosciences, Inc. using the CODEX™ technology.
Compare all formats
Cat # Size Price Quantity Check Availability Save
103101 50 µg 29€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103102 500 µg 92€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
IHC-F, CyTOF® - Verified
IP, CMCD, IHC, WB - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Application References

(PubMed link indicates BioLegend citation)
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Davies M, et al. 2017. PLoS Pathogens. 13(6):e1006435. PubMed
  2. Axelrod HD, et al. 2019. Mol Cancer Res. 17:356. PubMed
  3. Schneider H, et al. 2017. J Neurochem. 140:170. PubMed
  4. Shafer MER, et al. 2017. Stem Cell Reports. 1.040277778. PubMed
  5. Arnold IC, et al. 2019. PLoS Pathog. 15:e1007866. PubMed
  6. Wolf Y, et al. 2017. J Exp Med. 214:905. PubMed
  7. Hernández-Santana YE, et al. 2020. Life Sci Alliance. 3:00. PubMed
  8. Claveria-Cabello A, et al. 2020. Cancers (Basel). 12:00. PubMed
  9. Hutton C, et al. 2021. Cancer Cell. 39:1227. PubMed
  10. Li F, et al. 2020. EMBO J. 39:e103205. PubMed
  11. Liu CJ, et al. 2020. Neuro Oncol. 22:1276. PubMed
  12. Tremblay M, et al. 2020. Elife. 9: . PubMed
  13. Malinczak CA, et al. 2021. J Immunol. 206:1315. PubMed
  14. Li H, et al. 2022. Cancer Cell. 40:36. PubMed
  15. Ozga AJ, et al. 2022. Immunity. 55:82. PubMed
  16. Moore J, et al. 2022. Cancer Res. 82:365. PubMed
  17. Park JY, et al. 2022. Cell Rep. 38:110219. PubMed
  18. Valet C, et al. 2022. J Clin Invest. 132: . PubMed
  19. Lee NK, et al. 2022. Biomedicines. 10: . PubMed
  20. Moore AR, et al. 2022. Cell Rep. 41:111651. PubMed
  21. Li S, et al. 2022. Nat Commun. 13:7371. PubMed
  22. Abby E, et al. 2023. Nat Genet. 55:232. PubMed
  23. Potempa M, et al. 2022. J Immunol. 208:1742. PubMed
  24. Tarazi S, et al. 2022. Cell. 185:3290. PubMed
  25. Zhao Q, et al. 2023. Signal Transduct Target Ther. 8:40. PubMed
  26. Wang Y, et al. 2023. J Neuroinflammation. 20:41. PubMed
  27. García Fallit M, et al. 2023. Viruses. 15:. PubMed
  28. Xu J, et al. 2023. Discov Oncol. 14:68. PubMed
  29. Rafaiee R, et al. 2023. Bioimpacts. 13:97. PubMed
  30. Liu, M., Jin, S., et al. 2025. Nat Genet. 57(12),3075-3087. PubMed
  31. Komar, Z. M., Bavelaar, M., et al. 2025. Neoplasia. 68(0),101221. PubMed
  32. Duarte, J. M. N., Sahoglu, S. G., et al. 2025. J Am Heart Assoc. 14(20),e041945. PubMed
  33. Liu, Z., Yiu, B., et al. 2025. Nat Commun. 16(1),11479. PubMed
  34. Blomberg E, et al. 2022. Neurooncol Adv. 4:vdac148. PubMed
  35. Murai K, et al. 2022. Nat Commun. 13:6206. PubMed
  36. Kondo H, et al. 2020. J Biol Chem. 295:1658. PubMed
  37. Fernandes V, et al. 2020. PLoS Pathog. 16:e1008464. PubMed
  38. Nguyen R, et al. 2021. Cancer Immunol Immunother. 70:721. PubMed
  39. Wan Mohd Zawawi WFA, et al. 2021. Sci Rep. 11:10278. PubMed
  40. Maestro S, et al. 2021. Viruses. 13: . PubMed
  41. Reglero-Real N, et al. 2021. Immunity. :. PubMed
  42. Chamberlin T, et al. 2020. Cancer Research. 80(20):4465-4475. PubMed
  43. Li X, et al. 2020. Cell Rep. 31:107765. PubMed
  44. Vitiello GA, et al. 2018. Clin Cancer Res. 24:972. PubMed
  45. Rothchild AC, et al. 2019. Sci Immunol. 4:eaaw6693. PubMed
  46. Widjaja AA, et al. 2019. Gastroenterology. 157:777. PubMed
  47. Moon H et al. 2017. Cell stem cell. 21(5):665-678 . PubMed
  48. Rieck M, et al. 2017. Eur J Immunol. 47:677. PubMed
  49. Ajona D, et al. 2017. Cancer Discov. 0.773611111. PubMed
  50. Goel S, et al. 2017. Nature. 548:471. PubMed
  51. Wang W, et al. 2018. Cancer Cell. 34:757. PubMed
  52. Paulo E, et al. 2018. Sci Rep. 8:11001. PubMed
  53. Arnold IC, et al. 2018. J Exp Med. 215:2055. PubMed
  54. Heinrich A, et al. 2021. Cell Rep. 37:109885. PubMed
  55. Cooper STE, et al. 2022. Int J Mol Sci. 23:. PubMed
  56. Deppermann C, et al. 2020. J Exp Med. 217:. PubMed
  57. Dertschnig S, et al. 2020. J Clin Invest. 130:1896. PubMed
  58. Gao H, et al. 2021. J Virol. :. PubMed
  59. Dienz O, et al. 2020. J Immunol. 204:1521. PubMed
  60. Karhadkar TR, et al. 2021. J Pharmacol Exp Ther. 376:106. PubMed
  61. Liu X, et al. 2020. Nature. . PubMed
  62. Altshuler A, et al. 2021. Cell Stem Cell. 28(7):1248-1261.e8. PubMed
  63. Parlanti P, et al. 2020. Exp Eye Res. 194:107998. PubMed
  64. Lee S, et al. 2020. Cell Host & Microbe. 27(6):937-949. PubMed
  65. Thulasingam S, et al. 2019. Int J Mol Sci. 20. PubMed
  66. Gao J, et al. 2017. Oncol Lett. 14:2954. PubMed
  67. Starossom SC, et al. 2019. Nat Commun. 10:217. PubMed
  68. Zabaleta N, et al. 2018. Nat Commun. 9:5454. PubMed
  69. Zhu F, et al. 2019. J Immunol. 203:2644. PubMed
  70. Li Y et al. 2019. Endocrinology. 160(4):938-946 . PubMed
  71. Murad JP, et al. 2018. Front Immunol. 1.95. PubMed
  72. Schafflick D, et al. 2020. Nat Commun. 247:11. PubMed
  73. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  74. Wang G, et al. 2021. Nat Commun. 12:5733. PubMed
  75. Quintana E, et al. 2020. Cancer Res. 80:2889. PubMed
  76. Stefanescu C, et al. 2021. Front Oncol. 11:765151. PubMed
  77. Paprckova D, et al. 2022. Front Immunol. 13:1009198. PubMed
  78. Janghorban M, et al. 2022. Cancer Res. 82:885. PubMed
  79. Jackson JW, et al. 2021. Mol Ther Oncolytics. 22:444. PubMed
  80. Mayer KA, et al. 2021. FASEB J. 35:e21217. PubMed
  81. Delgobo M, et al. 2021. Front Immunol. 12:584538. PubMed
  82. Baraibar-Churio A, et al. 2021. Life (Basel). 11:. PubMed
  83. Nam J, et al. 2021. Front Cell Neurosci. 15:640084. PubMed
  84. Park S, et al. 2021. Nat Cell Biol. 23:476. PubMed
  85. Podd B, et al. 2006. J Immunol. 176:6532. PubMed
  86. Hitchcock JR, et al. 2020. FEBS J. 287:250. PubMed
  87. McLeod RL, et al. 2018. Oncotarget. 9:34459. PubMed
  88. Sutton C, et al. 2017. Nat Commun.. 10.1038/s41467-017-02111-0. PubMed
  89. Rhee S, et al. 2018. Nat Commun. 9:368. PubMed
  90. Finn J et al. 2019. Cell reports. 26(11):2942-2954 . PubMed
  91. Nolin JD, et al. 2017. JCI Insight. 2:e94929. PubMed
  92. Fiege JK, et al. 2019. PLoS Pathog. 15:e1008077. PubMed
  93. Silvestre-Roig C, et al. 2019. Nature. 569:236. PubMed
  94. Melchor SJ, et al. 2020. Sci Rep. 10:15724. PubMed
  95. Hagan AS, et al. 2020. Development. 147:00:00. PubMed
  96. O'Dea KP, et al. 2020. J Extracell Vesicles. 9:1706708. PubMed
  97. Baluk P, et al. 2020. Am J Pathol. 190:2355. PubMed
  98. Suzuki Y, et al. 2021. FEBS Open Bio. 11:2619. PubMed
  99. Gil-Melgosa L, et al. 2021. Biomedicines. 10:. PubMed
  100. He LD, et al. 2021. EMBO Rep. 22:e52196. PubMed
  101. Yim AKY, et al. 2022. Nat Neurosci. 25:238. PubMed
  102. Singh PP, et al. 2021. Ocul Surf. 21:271. PubMed
  103. Cassidy BR, et al. 2020. J Neuroinflammation. 17:259. PubMed
  104. Karhadkar TR, et al. 2021. PLoS One. 16:e0245924. PubMed
  105. Gereke M, et al. 2012. J Vis Exp. 70: 4322. PubMed
  106. Seelige R, et al. 2018. Sci Rep. 8:13670. PubMed
  107. Yoshihara S, et al. 2019. Front Immunol. 0.545833333. PubMed
  108. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  109. Peralta Ramos JM, et al. 2017. Front Immunol. 1.490277778. PubMed
  110. Ito S, et al. 2020. PLoS One. 15:e0229888. PubMed
  111. Latasa M, et al. 2010. PLoS One. 5:e15690. PubMed
  112. Fu H, et al. 2020. Front Immunol. 11:595813. PubMed
  113. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  114. Bruno KA, et al. 2021. Int J Mol Sci. 22:. PubMed
  115. Crawford LB, et al. 2020. Microorganisms. 8:. PubMed
  116. Liu H, et al. 2020. J Immunol. 205:1207. PubMed
  117. Shokirova H, et al. 2021. Sci Rep. 11:8647. PubMed
  118. Brown IK, et al. 2021. PLoS Pathog. 17:e1009602. PubMed
  119. Zhong L, et al. 2022. JCI Insight. 7:. PubMed
  120. Kenswil KJG, et al. 2021. Cell Stem Cell. 28(4):653-670.e11. PubMed
  121. Zareie P, et al. 2017. J Neuroinflammation. 0.630555556. PubMed
  122. Qiu X, et al. 2018. Lab Chip. 18:2776. PubMed
  123. Tsubaki T, et al. 2018. Oncotarget. 9:11209. PubMed
  124. Hoves S, et al. 2018. J Exp Med. 215:859. PubMed
  125. Vu LT, et al. 2019. J Extracell Vesicles. 8:1599680. PubMed
  126. Jones KB et al. 2018. Cell stem cell. 24(1):183-192 . PubMed
  127. Murai K et al. 2018. Cell stem cell. 23(5):687-699 . PubMed
  128. Morita S et al. 2017. Cell metabolism. 25(4):883-897 . PubMed
  129. Sheppard S, et al. 2018. Front Immunol. 1.630555556. PubMed
  130. Davies CL, et al. 2019. Front Immunol. 10:1048. PubMed
  131. Paharik AE, et al. 2017. Cell Host Microbe. 22:746. PubMed
  132. Nikolaou K, et al. 2014. EMBO J. 34:430. PubMed
  133. Johnson SA, et al. 2021. Eur J Immunol. 51:3228. PubMed
  134. Schuler CF, et al. 2020. Allergy. 75:2279. PubMed
  135. Yoon S, et al. 2020. Antioxidants (Basel). 10:. PubMed
  136. Hashimoto M, et al. 2021. J Neurochem. 156:834. PubMed
  137. Tao H, et al. 2021. Front Immunol. 12:623280. PubMed
  138. Scur M, et al. 2022. Nat Commun. 13:7272. PubMed
  139. Lopes N, et al. 2021. Nat Immunol. 22:179. PubMed
  140. Perdigoto AL, et al. 2022. JCI Insight. 7:. PubMed
  141. Ejima R, et al. 2021. Nutrients. 13:. PubMed
  142. Hu CF, et al. 2021. Front Immunol. 12:638381. PubMed
  143. Karhadkar TR, et al. 2020. bioRxiv. . PubMed
  144. Chen Q, et al. 2021. STAR Protocols. 2(1):100241. PubMed
  145. Matsuo K, et al. 2018. J Invest Dermatol. 138:1764. PubMed
  146. Bar O, et al. 2020. Fluids Barriers CNS. 17:27. PubMed
  147. Langer V, et al. 2019. J Clin Invest. 129:4691. PubMed
  148. Poulos MG, et al. 2017. J Clin Invest. 127:4163. PubMed
  149. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  150. Baluk P, et al. 2018. Methods Mol Biol. 1846:161. PubMed
  151. Fino KK, et al. 2017. Sci Rep. 5.334722222. PubMed
  152. Mensurado S, et al. 2018. PLoS Biol. 16:e2004990. PubMed
  153. Prizant H, et al. 2021. Cell Reports. 36:109523. PubMed
  154. Yu W, et al. 2020. J Clin Invest. . PubMed
  155. Geng T, et al. 2021. J Infect Dis. 223:2186. PubMed
  156. Ishigaki K, et al. 2021. Sci Rep. 11:13958. PubMed
  157. Tsukui H, et al. 2020. BMC Cancer. 20:411. PubMed
  158. Somasundaram R, et al. 2021. Blood. 137:3037. PubMed
  159. Wang Z, et al. 2021. Drug Discov Ther. 14:304. PubMed
  160. Levy BD, et al. 2020. J Allergy Clin Immunol. 145:335. PubMed
  161. Seo SU, et al. 2021. Front Immunol. 12:697162. PubMed
  162. Kim D, et al. 2019. Immune Netw. 19:e32. PubMed
  163. Chen X, et al. 2019. Methods Mol Biol. 2048:131. PubMed
  164. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  165. Moon H, et al. 2019. Nat Commun. 10:2225. PubMed
  166. Roussey JA, et al. 2017. J Immunol. 199:3535. PubMed
  167. Tamburini BAJ, et al. 2019. Front Immunol. 10:1036. PubMed
  168. Cha J, et al. 2015. J Biol Chem. 290:15337. PubMed
  169. Mori Y, et al. 2021. Diabetes and Vascular Disease Research. 18(3):14791641211027324. PubMed
  170. Dora D, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1617. PubMed
  171. Fahy N, et al. 2021. Front Immunol. 12:715267. PubMed
  172. Brownlie D, et al. 2021. J Immunother Cancer. 9:. PubMed
  173. Van Der Zande HJP, et al. 2021. FASEB J. 35:e21331. PubMed
  174. Penny HL, et al. 2021. Int J Mol Sci. 22:. PubMed
  175. Rincón E, et al. 2017. Oncotarget. 8:45415. PubMed
  176. Deng W et al. 2019. Cell reports. 27(6):1755-1768 . PubMed
  177. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  178. Lee YJ, et al. 2018. Front Microbiol. 9:83. PubMed
  179. Heinrich A, et al. 2020. Cell Rep. 31:107513. PubMed
  180. DeFalco T, et al. 2014. Proc Natl Acad Sci U S A. 111:2384. PubMed
  181. Li Y, et al. 2020. Elife. 9:00. PubMed
  182. Parodi B, et al. 2021. Front Immunol. 12:655212. PubMed
  183. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  184. Cané S, et al. 2021. J Immunother Cancer. 9:. PubMed
  185. Udumula MP, et al. 2021. Mol Metab. 53:101272. PubMed
  186. Van Winkle JA, et al. 2020. J Virol. 94:. PubMed
  187. Maier B, et al. 2020. Nature. 580:257. PubMed
  188. Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed
  189. Aikawa S, et al. 2020. Cell Death Differ. 1489:27. PubMed
  190. Diao J, et al. 2018. J Immunol. 201:1306. PubMed
  191. Pushalkar S, et al. 2018. Cancer Discov. 0.613194444. PubMed
  192. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  193. Stokes KL, et al. 2019. Oncogenesis. 8:24. PubMed
  194. Krenzlin H, et al. 2019. J Clin Invest. 130:1671. PubMed
  195. Winter C, et al. 2018. Cell Metab. 28:175. PubMed
  196. Huppé CA, et al. 2018. Mucosal Immunol. 0.536111111. PubMed
  197. Bernard S, et al. 2018. J Mammary Gland Biol Neoplasia. 23:249. PubMed
  198. Leist SR, et al. 2019. PLoS One. 14:e0220126. PubMed
  199. Zhang J, et al. 2019. Onco Targets Ther. 12:4985. PubMed
  200. Kästle M, et al. 2020. Cell Commun Signal. 183:18. PubMed
  201. Hassel C, et al. 2021. Front Immunol. 12:754661. PubMed
  202. Obst J, et al. 2020. Front Immunol. 11:579000. PubMed
  203. Dubik M, et al. 2021. Front Neurosci. 15:682451. PubMed
  204. Wilke JBH, et al. 2021. Mol Psychiatry. 26:7746. PubMed
  205. Umeda M, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  206. Kästele V, et al. 2021. Mucosal Immunol. 14:717. PubMed
  207. Shao Y, et al. 2017. Onco Targets Ther. 10:2675. PubMed
  208. He X, et al. 2017. Cancer Biol Ther. 0.815277778. PubMed
  209. Haber AL, et al. 2017. Nature. 551:333. PubMed
  210. Emrick JJ, et al. 2018. Proc Natl Acad Sci U S A. 115:E12091. PubMed
  211. Seehus CR, et al. 2017. Nat Commun. 8:1900. PubMed
  212. Cédile O, Wlodarczyk A, and Owens T 2017. APMIS.. 10.1111/apm.12740. PubMed
RRID
AB_312966 (BioLegend Cat. No. 103101)
AB_312967 (BioLegend Cat. No. 103102)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC,IHC-F,CyTOF®,IP,CMCD,IHC,WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC,CyTOF®,IP,CMCD,IHC,WB
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC,SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC,ICC,IHC,3D IHC,SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC,SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F,FC,3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC,SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC,CyTOF®
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Spark Blue™ 515 anti-mouse CD45 30-F11 FC
Spark UV™ 387 anti-mouse CD45 30-F11 FC
PE/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark PLUS UV395™ anti-mouse CD45 30-F11 FC
Spark Red™ 718 anti-mouse CD45 30-F11 FC
Spark YG™ 581 anti-mouse CD45 (Flexi-Fluor™) 30-F11 FC
Spark PLUS V475™ anti-mouse CD45 Antibody 30-F11 FC
StarBright UltraViolet 740 anti-mouse CD45 30-F11 FC
PE/Fire™ 744 anti-mouse CD45 30-F11 FC
StarBright UltraViolet 665 anti-mouse CD45 30-F11 FC
Go To Top Version: 3    Revision Date: 10.25.2018

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account